These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20117337)

  • 21. Alpha-defensins in the gastrointestinal tract.
    Cunliffe RN
    Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate immune dysfunction in inflammatory bowel disease.
    Gersemann M; Wehkamp J; Stange EF
    J Intern Med; 2012 May; 271(5):421-8. PubMed ID: 22324936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defensins and Paneth cells in inflammatory bowel disease.
    Shi J
    Inflamm Bowel Dis; 2007 Oct; 13(10):1284-92. PubMed ID: 17567878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human defensins in Crohn's disease.
    Wehkamp J; Fellermann K; Stange EF
    Chem Immunol Allergy; 2005; 86():42-54. PubMed ID: 15976487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crohn's disease--defect in innate defence.
    Gersemann M; Wehkamp J; Fellermann K; Stange EF
    World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease.
    Aldhous MC; Nimmo ER; Satsangi J
    Gut; 2003 Nov; 52(11):1533-5. PubMed ID: 14570717
    [No Abstract]   [Full Text] [Related]  

  • 27. The mechanism of action of probiotics.
    Boirivant M; Strober W
    Curr Opin Gastroenterol; 2007 Nov; 23(6):679-92. PubMed ID: 17906447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paneth cell function--implications in pediatric Crohn disease.
    Beisner J; Stange EF; Wehkamp J
    Gut Microbes; 2011; 2(1):47-51. PubMed ID: 21637018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease.
    Beisner J; Teltschik Z; Ostaff MJ; Tiemessen MM; Staal FJ; Wang G; Gersemann M; Perminow G; Vatn MH; Schwab M; Stange EF; Wehkamp J
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G487-98. PubMed ID: 24994854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.
    Kübler I; Koslowski MJ; Gersemann M; Fellermann K; Beisner J; Becker S; Rothfuss K; Herrlinger KR; Stange EF; Wehkamp J
    Aliment Pharmacol Ther; 2009 Sep; 30(6):621-33. PubMed ID: 19549264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paneth cells and inflammation dance together in Crohn's disease.
    Kaser A; Blumberg RS
    Cell Res; 2008 Dec; 18(12):1160-2. PubMed ID: 19043437
    [No Abstract]   [Full Text] [Related]  

  • 34. Defensin-mediated innate immunity in the small intestine.
    Ouellette AJ
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):405-19. PubMed ID: 15123078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paneth cells: leukocyte-like mediators of innate immunity in the intestine.
    Keshav S
    J Leukoc Biol; 2006 Sep; 80(3):500-8. PubMed ID: 16793911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defensins in the immunology of bacterial infections.
    Menendez A; Brett Finlay B
    Curr Opin Immunol; 2007 Aug; 19(4):385-91. PubMed ID: 17702560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
    Stange EF; Schmid M; Fellermann K; Wehkamp J
    Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
    Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
    Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced mucosal antimicrobial activity in Crohn's disease of the colon.
    Nuding S; Fellermann K; Wehkamp J; Stange EF
    Gut; 2007 Sep; 56(9):1240-7. PubMed ID: 17456510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.